E2F2 Antikörper (Middle Region)
-
- Target Alle E2F2 Antikörper anzeigen
- E2F2 (E2F Transcription Factor 2 (E2F2))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Maus, Ratte, Kaninchen, Hund, Rind (Kuh), Meerschweinchen, Pferd
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser E2F2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- QWVGRGMFED PTRPGKQQQL GQELKELMNT EQALDQLIQS CSLSFKHLTE
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 90%, Rabbit: 86%, Rat: 93%
- Produktmerkmale
- This is a rabbit polyclonal antibody against E2F2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human E2F2
- Top Product
- Discover our top product E2F2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 437 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies." in: Human molecular genetics, Vol. 12, Issue 20, pp. 2625-35, (2003) (PubMed).
: "
-
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies." in: Human molecular genetics, Vol. 12, Issue 20, pp. 2625-35, (2003) (PubMed).
-
- Target
- E2F2 (E2F Transcription Factor 2 (E2F2))
- Andere Bezeichnung
- E2F2 (E2F2 Produkte)
- Synonyme
- E2F-2 antikoerper, CG1071 antikoerper, Dmel\\CG1071 antikoerper, E2F antikoerper, E2F2 antikoerper, dE2F-2 antikoerper, dE2F2 antikoerper, dE2f2 antikoerper, de2f2 antikoerper, e2f2 antikoerper, 9230110J10 antikoerper, E130207A07 antikoerper, fb40b03 antikoerper, wu:fb40b03 antikoerper, E2F transcription factor 2 antikoerper, si:ch211-160f23.5 antikoerper, E2F2 antikoerper, E2f2 antikoerper, si:ch211-160f23.5 antikoerper
- Hintergrund
-
E2F2 is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F pro
Alias Symbols: E2F-2
Protein Interaction Partner: RB1, GNB5, GIT2, TFDP1, RBL1, ARID3A, ELAVL1, ATAD2, KMT2D, KMT2A, RYBP, SETD8, BCAR1, TFDP2, BRD2, YY1, SP1, CDK3, RNF144A, FHL2, SPIB, RBL2, E2F4, MYBL2, EAPP, TP53BP2, PPP1R13B, TP53INP1, JMY, GAB2, CDC25A, CDC6, E2F1, UXT, MT1G,
Protein Size: 437 - Molekulargewicht
- 48 kDa
- Gen-ID
- 1870
- NCBI Accession
- NM_004091, NP_004082
- UniProt
- Q14209
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases, DNA Replication
-